Thomas Braxton King

CIK: 0001279309

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)1 (20.0%)

Derivative conversions

Awards (A)3 (60.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ACHV

ACHIEVE LIFE SCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

ACHV
ACHIEVE LIFE SCIENCES, INC.
Sep 4, 2025
Exercise(M)
Direct
455K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Sep 4, 2025
Sale(S)
Direct
139.9K shares at avg. $2.77$387K
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jun 6, 2025
Award(A)
Stock Option (right to buy)
Direct
31.5K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jan 13, 2025
Award(A)
Performance Restricted Stock Unit (PRSU)
Direct
455K shares-
ACHV
ACHIEVE LIFE SCIENCES, INC.
Jan 13, 2025
Award(A)
Stock Option (right to buy)
Direct
195K shares-

		Type	Shares	Price		Ownership
Sep 4, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Exercise(M)	455,000	-	-	Direct
Sep 4, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Sale(S)	139,858	$2.77	$387,407	Direct
Jun 6, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	31,500	-	-	Direct
Jan 13, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Performance Restricted Stock Unit (PRSU)	455,000	-	-	Direct
Jan 13, 2025	ACHV ACHIEVE LIFE SCIENCES, INC.	Award(A) Stock Option (right to buy)	195,000	-	-	Direct

1-5 of 5 transactions

About KING THOMAS BRAXTON

KING THOMAS BRAXTON (SEC CIK 0001279309) files insider reports with the SEC as Executive Chairman of ACHIEVE LIFE SCIENCES, INC. (ACHV).

Signal8 holds 3 ownership filings by KING THOMAS BRAXTON, all Form 4s, filed between Jan 14, 2025 and Sep 8, 2025. Those filings report 5 transactions, from Jan 13, 2025 to Sep 4, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on KING THOMAS BRAXTON's filings is in BOTHELL, WA.

Recent filings by KING THOMAS BRAXTON

Sep 4, 2025: Option exercise of ACHV shares (Form 4, code M).
Sep 4, 2025: Open-market sale of ACHV shares (Form 4, code S).
Jun 6, 2025: Grant or award of ACHV derivative securities (Form 4, code A).
Jan 13, 2025: Grants or awards of ACHV derivative securities (2 lines, Form 4, code A).

Other insiders filing for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Halladay Benjamin, Chief Financial Officer
Stewart Richard Alistair, Director
Sellig Thomas, Director
Martin Christopher Nathan, Director
Royston Aaron, Director
Waldman Reid Alexander, Director

How to read Form 4 transaction codes